Clinical Trials Browser

Terminated × Solid Tumor × Sunitinib × Clear all

NCT00982657 2015-11-20

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Phase 2 Terminated

34 enrolled 10 charts

Other solid neoplasm

Solid Tumor